Penumbra Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon. Welcome to the second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst here at Morgan Stanley. It's my pleasure to have Adam Elsesser, CEO of Penumbra here with us today. Really quickly, disclosure, www.morganstanley.com/disclosures. Adam, with that, thank you very much for being here with us.
Yes. Thanks for having us again. Appreciate it.
Questions & Answers
Wanted to start with the macro, as that seems to be the key topical point these days. But as you think about 2Q, you talked about staffing, a little bit of contrast. I get the sense contrast is largely behind us. That was more of a U.S. dynamic.
But as you think about your business, your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
